Depomed fights the FDA — and wins

Who says you can't fight the drug development equivalent of city hall? Depomed Inc. won a summary judgment, the company said, requiring the Food and Drug Administration to give orphan drug exclusivity to Gralise, the company's treatment for nerve pain due to shingles...